Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Hemorrhage 1 Carcinoma, Renal Cell 1

Interventions

pembrolizumab 69 Nivolumab 67 cabozantinib 45 Ipilimumab 36 Specimen Handling 32 Magnetic Resonance Spectroscopy 32 lenvatinib 26 Axitinib 25 belzutifan 21 Sunitinib 17 Biopsy 15 Radiosurgery 14 CTLA-4 Antigen 13 atezolizumab 12 Everolimus 10 pazopanib 8 fludarabine 8 avelumab 8 Bevacizumab 8 toripalimab 7 cemiplimab 7 Nephrectomy 7 Immunoglobulin G 7 Cyclophosphamide 7 aldesleukin 6 Standard of Care 6 Radiotherapy 6 Blood Specimen Collection 6 spartalizumab 5 palbociclib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × FloSeal Matrix × 1 year × Clear all

NCT07232927 2025-11-18

HEMOSTA-PN

Ankara University

Phase NA Completed

Carcinoma, Renal Cell, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡